The DOI matches its Crossref record; 60 of the 60 references it cites were found in a registry or an index.
Bridging solubility between drug discovery and development
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lipinski, C. A., Lombardo, F., Dominy, B. W., & Feeney, P. J. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00129-0 · Cited by 18,139
Lipinski, C. A., Lombardo, F., Dominy, B. W., & Feeney, P. J. (1997) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(96)00423-1 · Cited by 11,385
Amidon, G. L., Lennernäs, H., Shah, V. P., & Crison, J. R. (1995) · Pharmaceutical Research · doi:10.1023/a:1016212804288 · Cited by 5,430
Drug-like properties and the causes of poor solubility and poor permeability
Lipinski, C. A. (2000) · Journal of Pharmacological and Toxicological Methods · doi:10.1016/s1056-8719(00)00107-6 · Cited by 3,734
Physiological Parameters in Laboratory Animals and Humans
Davies, B., & Morris, T. (1993) · Pharmaceutical Research · doi:10.1023/a:1018943613122 · Cited by 2,926
Reaching for high-hanging fruit in drug discovery at protein–protein interfaces
Wells, J. A., & McClendon, C. L. (2007) · Nature · doi:10.1038/nature06526 · Cited by 1,960
Prodrugs: design and clinical applications
Rautio, J., Kumpulainen, H., Heimbach, T., Oliyai, R., Oh, D., Järvinen, T., & Savolainen, J. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2468 · Cited by 1,630
Solubilizing Excipients in Oral and Injectable Formulations
Strickley, R. G. (2004) · Pharmaceutical Research · doi:10.1023/b:pham.0000016235.32639.23 · Cited by 1,415
What is the True Solubility Advantage for Amorphous Pharmaceuticals?
Hancock, B. C., & Parks, M. (2000) · Pharmaceutical Research · doi:10.1023/a:1007516718048 · Cited by 1,358
Nanosizing — Oral formulation development and biopharmaceutical evaluation
Kesisoglou, F., Panmai, S., & Wu, Y. (2007) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.05.003 · Cited by 1,055
Prediction of drug solubility from structure
Jorgensen, W. L., & Duffy, E. M. (2002) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00008-x · Cited by 891
Lipophilicity in drug discovery
Waring, M. J. (2010) · Expert Opinion on Drug Discovery · doi:10.1517/17460441003605098 · Cited by 873
Tamoxifen: a most unlikely pioneering medicine
Jordan, V. C. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1031 · Cited by 824
Drug-Like Properties: Concepts, Structure Design and Methods from ADME to Toxicity Optimization
Kerns, E. H., & Di, L. (2016) · Cited by 784
Self-citationUse of a Glutaric Acid Cocrystal to Improve Oral Bioavailability of a Low Solubility API
McNamara, D. P., Childs, S. L., Giordano, J., Iarriccio, A., Cassidy, J., Shet, M. S., Mannion, R., O'Donnell, E., & Park, A. (2006) · Pharmaceutical Research · doi:10.1007/s11095-006-9032-3 · Cited by 690
Ishikawa, M., & Hashimoto, Y. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm101356p · Cited by 619
Hydroxypropyl Methylcellulose Acetate Succinate-Based Spray-Dried Dispersions: An Overview
Friesen, D. T., Shanker, R., Crew, M., Smithey, D. T., Curatolo, W. J., & Nightingale, J. A. S. (2008) · Molecular Pharmaceutics · doi:10.1021/mp8000793 · Cited by 610
Biopharmaceutics Classification System: The Scientific Basis for Biowaiver Extensions
Yu, L. X., Amidon, G. L., Polli, J. E., Zhao, H., Mehta, M. U., Conner, D. P., Shah, V. P., Lesko, L. J., Chen, M.-L., Lee, V. H. L., et al. (2002) · Pharmaceutical Research · doi:10.1023/a:1016473601633 · Cited by 571
Prodrug strategies to overcome poor water solubility
Stella, V. J., & Nti-Addae, K. W. (2007) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.05.013 · Cited by 554
Fleisher, D., Li, C., Zhou, Y., Pao, L., & Karim, A. (1999) · Clinical Pharmacokinetics · doi:10.2165/00003088-199936030-00004 · Cited by 506
Trends in Solubility of Polymorphs
Pudipeddi, M., & Serajuddin, A. T. M. (2005) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20302 · Cited by 505
Impact of solid state properties on developability assessment of drug candidates
Huang, L. (2004) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2003.10.007 · Cited by 438
High throughput solubility measurement in drug discovery and development
Alsenz, J., & Kansy, M. (2007) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.05.007 · Cited by 412
Lessons Learned from Marketed and Investigational Prodrugs
Ettmayer, P., Amidon, G. L., Clement, B., & Testa, B. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm0303812 · Cited by 384
Bevan, C. D., & Lloyd, R. S. (2000) · Analytical Chemistry · doi:10.1021/ac9912247 · Cited by 345
Drug-Like Property Concepts in Pharmaceutical Design
Di, L., Kerns, E., & Carter, G. (2009) · Current Pharmaceutical Design · doi:10.2174/138161209788682479 · Cited by 327
Self-citationImpact of excipients on the absorption of P-glycoprotein substrates in vitro and in vivo
Cornaire, G., Woodley, J., Hermann, P., Cloarec, A., Arellano, C., & Houin, G. (2004) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2004.03.001 · Cited by 307
Paulekuhn, G. S., Dressman, J. B., & Saal, C. (2007) · Journal of Medicinal Chemistry · doi:10.1021/jm701032y · Cited by 304
Leach, A. G., Jones, H. D., Cosgrove, D. A., Kenny, P. W., Ruston, L., MacFaul, P., Wood, J. M., Colclough, N., & Law, B. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm0605233 · Cited by 277
Hit discovery and hit-to-lead approaches
Keserű, G. M., & Makara, G. M. (2006) · Drug Discovery Today · doi:10.1016/j.drudis.2006.06.016 · Cited by 256
Developing early formulations: Practice and perspective
Li, P., & Zhao, L. (2007) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2007.05.049 · Cited by 225
Oral Controlled Release Formulation Design and Drug Delivery: Theory to Practice
(2010) · Wiley eBooks · doi:10.1002/9780470640487 · Cited by 214
Solubility and Dissolution Profile Assessment in Drug Discovery
Sugano, K., Okazaki, A., Sugimoto, S., Tavornvipas, S., Omura, A., & Mano, T. (2007) · Drug Metabolism and Pharmacokinetics · doi:10.2133/dmpk.22.225 · Cited by 212
Self-citationModelling and PBPK Simulation in Drug Discovery
Jones, H. M., Gardner, I. B., & Watson, K. J. (2009) · The AAPS Journal · doi:10.1208/s12248-009-9088-1 · Cited by 202
Biological assay challenges from compound solubility: strategies for bioassay optimization
Di, L., & Kerns, E. H. (2006) · Drug Discovery Today · doi:10.1016/j.drudis.2006.03.004 · Cited by 181
Self-citationComputational approaches to determine drug solubility
Faller, B., & Ertl, P. (2007) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.05.005 · Cited by 172
Predicting Effect of Food on Extent of Drug Absorption Based on Physicochemical Properties
Gu, C., Li, H., Levons, J. K., Lentz, K. A., Gandhi, R. B., Raghavan, K. S., & Smith, R. L. (2007) · Pharmaceutical Research · doi:10.1007/s11095-007-9236-1 · Cited by 158
Jones, H. M., Parrott, N. J., Ohlenbusch, G., & Lav, T. (2006) · Clinical Pharmacokinetics · doi:10.2165/00003088-200645120-00006 · Cited by 155
Zhou, L., Yang, L., Tilton, S., & Wang, J. (2007) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20913 · Cited by 155
Introduction to computational oral absorption simulation
Sugano, K. (2009) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425250902835506 · Cited by 136
Engers, D. A., Teng, J., Jimenez-Novoa, J., Gent, P., Hossack, S., Campbell, C., Thomson, J., Ivanisevic, I., Templeton, A. G. B., Byrn, S. R., et al. (2010) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.22233 · Cited by 130
P-glycoprotein and surfactants: Effect on intestinal talinolol absorption
Bogman, K., Aschmann, Y. Z., DEGEN, L., Gérard Hopfgartner, D., Gutmann, H., Alsenz, J., & Drewe, J. (2005) · Clinical Pharmacology & Therapeutics · doi:10.1016/j.clpt.2004.09.001 · Cited by 126
Solvent Systems and Their Selection in Pharmaceutics and Biopharmaceutics
Augustijns, P., & Brewster, M. E. (2007) · Springer eBooks · doi:10.1007/978-0-387-69154-1 · Cited by 124
An intravenous formulation decision tree for discovery compound formulation development
Lee, Y.-C., Zocharski, P., & Samas, B. (2003) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(02)00704-4 · Cited by 102
Theoretical Dissolution Model of Poly-Disperse Drug Particles in Biorelevant Media
Okazaki, A., Mano, T., & Sugano, K. (2007) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21070 · Cited by 97
Self-citationSugano, K., Kataoka, M., Mathews, C. D. C., & Yamashita, S. (2010) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2010.03.011 · Cited by 96
Shono, Y., Jantratid, E., & Dressman, J. (2011) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2011.04.005 · Cited by 90
High throughput microsomal stability assay for insoluble compounds
Di, L., Kerns, E. H., Li, Q. S., & Petusky, S. L. (2006) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2006.03.007 · Cited by 77
Self-citationEnhanced bioavailability of piroxicam via salt formation with ethanolamines
Gwak, H. S., Choi, J., & CHOI, H. (2005) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2005.03.016 · Cited by 76
Zimmerman, J. J., Ferron, G. M., Lim, H., & Parker, V. D. (1999) · The Journal of Clinical Pharmacology · doi:10.1177/009127009903901107 · Cited by 73
Popa-Burke, I. G., Issakova, O., Arroway, J. D., Bernasconi, P., Chen, M., Coudurier, L., Galasinski, S., Jadhav, A., Janzen, W., Lagasca, D., et al. (2004) · Analytical Chemistry · doi:10.1021/ac0491859 · Cited by 73
Palucki, M., Higgins, J. D., Kwong, E. C., & Templeton, A. C. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm1002638 · Cited by 72
High throughput solubility measurement with automated polarized light microscopy analysis
Sugano, K., Kato, T., Suzuki, K., Keiko, K., Sujaku, T., & Mano, T. (2006) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20628 · Cited by 71
Self-citationBadawy, S. I. F., Gray, D. B., Zhao, F., Sun, D., Schuster, A. E., & Hussain, M. A. (2006) · Pharmaceutical Research · doi:10.1007/s11095-006-9899-z · Cited by 67
Lundquist, J. T. I., Harnish, D. C., Kim, C. Y., Mehlmann, J. F., Unwalla, R. J., Phipps, K. M., Crawley, M. L., Commons, T., Green, D. M., Xu, W., et al. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm901650u · Cited by 53
Johnson, S. R., Chen, X., Murphy, D. K., & Gudmundsson, O. S. (2007) · Molecular Pharmaceutics · doi:10.1021/mp070030+ · Cited by 37
The Emerging Utility of Co-Crystals in Drug Discovery and Development
Meanwell, N. A. (2008) · Annual reports in medicinal chemistry · doi:10.1016/s0065-7743(08)00022-5 · Cited by 33
Solubility Issues in Early Discovery and HTS
Di, L., & Kerns, E. H. (2007) · Springer eBooks · doi:10.1007/978-0-387-69154-1_4 · Cited by 24
Self-citationPreformulation Consideration for Drugs in Oral CR Formulation
Ku, M. S. (2010) · Wiley eBooks · doi:10.1002/9780470640487.ch4 · Cited by 8
Physiological Factors in Drug Absorption
Davis, S. S. (1991) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1991.tb27242.x · Cited by 5
Cited by
Strategies to Address Low Drug Solubility in Discovery and Development
Williams, H. D., Trevaskis, N. L., Charman, S. A., Shanker, R. M., Charman, W. N., Pouton, C. W., & Porter, C. J. H. (2013) · Pharmacological Reviews · doi:10.1124/pr.112.005660 · Cited by 1,570
The expanding role of prodrugs in contemporary drug design and development
Rautio, J., Meanwell, N. A., Di, L., & Hageman, M. J. (2018) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2018.46 · Cited by 767
Self-citationPharmaceutical amorphous solid dispersion: A review of manufacturing strategies
Bhujbal, S. V., Mitra, B., Jain, U., Gong, Y., Agrawal, A., Karki, S., Taylor, L. S., Kumar, S., & (Tony) Zhou, Q. (2021) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2021.05.014 · Cited by 556
Multifunctional polymeric micelles for delivery of drugs and siRNA
Jhaveri, A. M., & Torchilin, V. P. (2014) · Frontiers in Pharmacology · doi:10.3389/fphar.2014.00077 · Cited by 466
Meier-Menches, S. M., Gerner, C., Berger, W., Hartinger, C. G., & Keppler, B. K. (2018) · Chemical Society Reviews · doi:10.1039/c7cs00332c · Cited by 425
Metadata
- Authors
- Di, L., Fish, P. V., & Mano, T.
- Venue
- Drug Discovery Today
- Publisher
- Elsevier BV
- Published
- 2012-05
- Volume
- 17
- Issue
- 9-10
- Pages
- 486-495
- ISSN
- 1359-6446 (ISSN-L)
- OpenAlex
- W2047161363
- Cited by
- 491
- References
- 60
- FWCI
- 6.10
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.